-29.5%
MRNA vs AFRM
-58.2%
+28.7%
-93.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | AFRM | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.3% | -3.4% | +4.7% | +2.1% |
| 7D | -13.8% | -13.6% | -0.3% | -10.9% |
| 30D | -17.7% | -22.9% | +5.3% | -12.4% |
| 3M | +14.3% | -26.4% | +40.7% | +22.7% |
| 6M | +336.0% | -12.8% | +348.8% | +354.4% |
| YTD | +575.9% | -23.5% | +599.5% | +614.5% |
| 1Y | +724.4% | -12.9% | +737.3% | +749.7% |
| 3Y | +160.8% | +129.6% | +31.2% | +100.6% |
| All | -29.5% | -58.2% | +28.7% | -31.2% |
Cumulative growth
Daily Returns
Daily percentage return beside AFRM.
Daily Out/Under-Performance
Portfolio return minus AFRM return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × AFRM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded AFRM wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling